NEW YORK, June 5 /PRNewswire/ -- Chandler Chicco Companies (CCC), an inVentiv Health (Nasdaq: VTIV) global healthcare communications network, today announced the US launch of Brandtectonics Access, a specialist market access consultancy that designs, facilitates and delivers unique, tailored solutions to optimize patient access to pharmaceutical brands. The US arm of Brandtectonics Access will be headquartered in New York, while European operations are headquartered in London.
"Market access is one of the greatest challenges facing the pharmaceutical industry today and, at a global level, we have seen tremendous growth in this area in the last few years," said Bob Chandler, Principal, Chandler Chicco Companies. "Our Brandtectonics Access Europe team has created visionary new approaches that help our pharmaceutical clients overcome many of the market access hurdles their brands face - from supporting clinical trial enrollment to end-of-lifecycle strategies. We're eager to build on that momentum here in the US, where we see the opportunity to expand our offering even further, starting with clinical trial enhancement."
In the US, Brandtectonics Access will focus on evidence-based and innovative clinical trial-specific approaches to help overcome enrollment challenges, creating the long-term partnerships critical for optimal market access. US services will support and deliver global clinical trial enhancement programs in partnership with the established European Brandtectonics Access team, as well as deliver US-specific programs.
About Chandler Chicco Companies
Chandler Chicco Companies is a network of global companies representing best-in-class capabilities in healthcare communications across public relations, marketing and branding, graphic design, media and production, and research and measurement. Chandler Chicco Companies include: Chandler Chicco Agency, Biosector 2, Litmus, Determinus, 'nition, Allidura Consumer, Brandtectonics Access, Brandtectonics ID and Chandler Chicco Productions.
CCC has wholly-owned offices in London, Los Angeles, Paris, New York and Washington, D.C. and was named European Healthcare Consultancy of the Year in 2008 by The Holmes Report. The company also has a global affiliate healthcare network of 22 national companies operating across 37 markets. For more information, visit www.chandlerchiccocompanies.com.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
|SOURCE Chandler Chicco Companies|
Copyright©2009 PR Newswire.
All rights reserved